Acasă › Cancer pulmonar cu celule non-pătrate › Arizona › Phoenix
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Phoenix, AZ
20 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Phoenix (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
În curs de recrutareFaza 1
- Exelixis Clinical Site #67, Phoenix
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 1/2
- Research Site, Phoenix
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Ironwood Cancer & Research Centers, Phoenix
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
În curs de recrutareStudiu observațional
- Mayo Clinic Hospital, Phoenix
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
În curs de recrutareFaza 3
- Mayo Clinic in Arizona - Phoenix ( Site 0147), Phoenix
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- City of Hope, Phoenix, Phoenix
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
În curs de recrutareFaza 3
- Clinical Study Site, Phoenix
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Banner University Medical Center Phoenix, Phoenix
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
În curs de recrutareFaza 1
- Mayo Clinic, Phoenix
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
În curs de recrutareFaza 1/2
- Mayo Clinic Arizona, Phoenix
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
În curs de recrutareFaza 1/2
- Mayo Clinic Arizona, Phoenix
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
În curs de recrutareFaza 3
- Mayo Clinic Hospital in Arizona, Phoenix
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
În curs de recrutareFaza 1/2
- Mayo Clinic Hospital - Arizona, Phoenix
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
În curs de recrutareFaza 1/2
- USOR HonorHealth, Phoenix
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
În curs de recrutareFaza 1
- Mayo Clinic Hospital, Phoenix
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
În curs de recrutareFaza 1
- Mayo Clinic Hospital, Phoenix
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
În curs de recrutareFaza 3
- Mayo Clinic Hospital in Arizona, Phoenix
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
În curs de recrutareFaza 1
- Mayo Clinic Comprehensive Cancer Center, Phoenix
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- Cancer Center at Saint Joseph's, Phoenix
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
În curs de recrutareStudiu observațional
- Mayo Clinic in Arizona, Phoenix
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY120 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH56 studii
- Washington, DC55 studii
Alte studii în Phoenix
- Cancer de sân25 studii
- Cancer colorectal25 studii
- Obezitate22 studii
- Cancer metastatic20 studii
- Insuficiență cardiacă18 studii
- Cancer de prostată17 studii
- Cancer (toate tipurile)17 studii
- Mielom multiplu16 studii
- Cancer pancreatic16 studii
- Boli cardiovasculare16 studii
- Boala Alzheimer15 studii
- Supraponderalitate15 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.